Molecular and cellular modulation of fibrinolysis
- PMID: 12669114
Molecular and cellular modulation of fibrinolysis
Abstract
The structure of the fibrin network, the hemodynamic environment of the clot, the kinetic properties of the fibrinolytic enzymes and the balance of their formation and inactivation essentially determine the effectiveness of fibrinolysis in vivo. The fibrin structure and the action of proteases, however depend considerably on additional, apparently inert physiological and pathological factors, which are restricted to more or less transient compartments in fluid-solid interface, such as thrombus (fibrin with platelet membrane structures), endothelial cell surface, the environment of polymorphonuclear cells (PMN). In these compartments extreme changes in concentrations and rate enhancements are observed. Components released by endothelial cells, PMNs and platelets or molecules present in circulating blood create a heterogeneous milieu that modulates fibrinolysis. This review summarizes the effects, and where it is possible, explains the mechanism of modulators of the fibrinolytic processes, such as cell membrane and cellular contents of endothelium, PMN and platelets present in thrombi, the action of normal and pathological blood plasma- and extracellular matrix-components.
Similar articles
-
[Fibrinolysis modulators].Orv Hetil. 2002 Mar 17;143(11):541-5. Orv Hetil. 2002. PMID: 12583322 Review. Hungarian.
-
Influence of plasminogen deficiency on the contribution of polymorphonuclear leucocytes to fibrin/ogenolysis: studies in plasminogen knock-out mice.Thromb Haemost. 2002 Nov;88(5):805-10. Thromb Haemost. 2002. PMID: 12428098
-
Polymorphonuclear leucocytes have two opposing roles in fibrinolysis.Thromb Haemost. 2002 Jun;87(6):1006-10. Thromb Haemost. 2002. PMID: 12083479
-
Fibrinolysis at the fluid-solid interface of thrombi.Curr Med Chem Cardiovasc Hematol Agents. 2005 Oct;3(4):341-55. doi: 10.2174/156801605774322337. Curr Med Chem Cardiovasc Hematol Agents. 2005. PMID: 16250865 Review.
-
DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment.Thromb Haemost. 2015 Jun;113(6):1289-98. doi: 10.1160/TH14-08-0669. Epub 2015 Mar 19. Thromb Haemost. 2015. PMID: 25789443
Cited by
-
1,2,3-Triazole Derivatives as Novel Antifibrinolytic Drugs.Int J Mol Sci. 2022 Nov 29;23(23):14942. doi: 10.3390/ijms232314942. Int J Mol Sci. 2022. PMID: 36499270 Free PMC article.
-
Transitional Remodeling of the Hepatic Extracellular Matrix in Alcohol-Induced Liver Injury.Biomed Res Int. 2016;2016:3162670. doi: 10.1155/2016/3162670. Epub 2016 Oct 24. Biomed Res Int. 2016. PMID: 27843941 Free PMC article. Review.
-
Impact of homocysteine-thiolactone on plasma fibrin networks.J Thromb Thrombolysis. 2014 Nov;38(4):540-5. doi: 10.1007/s11239-014-1063-8. J Thromb Thrombolysis. 2014. PMID: 24659173
-
Hemostatic Testing in Critically Ill Infants and Children.Front Pediatr. 2021 Jan 8;8:606643. doi: 10.3389/fped.2020.606643. eCollection 2020. Front Pediatr. 2021. PMID: 33490001 Free PMC article. Review.
-
Activities of wild-type and variant tissue-type plasminogen activators retained on vascular endothelial cells.FEBS Open Bio. 2016 Apr 1;6(5):469-76. doi: 10.1002/2211-5463.12057. eCollection 2016 May. FEBS Open Bio. 2016. PMID: 27419052 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources